Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Capital Expenditures (2023 - 2026)

Adagio Medical Holdings has reported Capital Expenditures over the past 4 years, most recently at $2000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 99.4% to $2000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $424000.0 through Mar 2026, down 60.63% year-over-year, with the annual reading at $374000.0 for FY2025, 70.78% down from the prior year.
  • Capital Expenditures was $2000.0 for Q1 2026 at Adagio Medical Holdings, up from -$491000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $578000.0 in Q3 2024 and troughed at -$491000.0 in Q4 2025.
  • The 4-year median for Capital Expenditures is $2000.0 (2024), against an average of $40285.7.
  • Year-over-year, Capital Expenditures skyrocketed 106.79% in 2025 and then tumbled 99.4% in 2026.
  • A 4-year view of Capital Expenditures shows it stood at -$306000.0 in 2023, then soared by 288.89% to $578000.0 in 2024, then tumbled by 184.95% to -$491000.0 in 2025, then surged by 100.41% to $2000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Capital Expenditures are $2000.0 (Q1 2026), -$491000.0 (Q4 2025), and $335000.0 (Q1 2025).